Protective role of statins during anticoagulation for venous thromboembolism: beyond their lipid lowering effect?

Venous thromboembolism (VTE) is a leading cause of morbidity and mortality [1]. VTE represents a major health problem for high prevalence, incidence, and costs [2]. The number of people affected by VTE is unknown, although as many as 900,000 people could be affected (1 to 2 per 1,000) each year in the United States [2]. Estimates suggest that 10 to 30% of people will die within one month of diagnosis and that sudden death is the first symptom in...